Search for: "Teva Pharmaceuticals USA Inc" Results 261 - 280 of 422
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Jul 2011, 4:06 pm by Lawrence B. Ebert
The court granted leave to file briefs amici curiae to Teva Pharmaceuticals, USA, Inc., Mylan Pharmaceuticals Inc., Apotex Inc. and Impax Laborato- ries, Inc., Consumer Federation of America and National Legislative Association on Prescription Drug Prices, and Generic Pharmaceutical Association.The petition for rehearing was considered by the panel that heard the appeal, and thereafter the petition for rehearing en… [read post]
25 Feb 2020, 2:10 am by Courtenay C. Brinckerhoff
Teva Pharmaceuticals USA, Inc., is a non-precedential decision that was issued on the briefs (without oral argument), but is worth reviewing for its discussion of anticipation and inherency in the context of method of treatment claims. [read post]
8 Mar 2017, 8:03 pm by Lawrence B. Ebert
Because we see no error in these rulings, we affirmthe district court’s entry of judgment against Sprint.Teva gets cited as to "claim construction":The proper construction of a patent’s claims is an issueof Federal Circuit law, and we apply the frameworkset forth in Teva Pharmaceuticals USA, Inc. v. [read post]
20 Sep 2011, 6:35 am by Bexis
Teva Pharmaceuticals USA, Inc., 2011 WL 4025734 (S.D. [read post]
30 Apr 2021, 8:07 am by Dan Bressler
Barclay Surrick to require Morgan Lewis to answer a series of questions about its ability to ethically represent Glenmark Pharmaceuticals Inc. [read post]
15 May 2023, 7:21 am by Dennis Crouch
” This petition has a minimal likelihood of being granted. = = = = The court also denied certiorari in the skinny-label FDA-Patent case of Teva Pharmaceuticals USA, Inc. v. [read post]
18 Mar 2010, 2:30 am
Teva Pharmaceuticals USA, Inc. et al. and Gilead Sciences, Inc., et al. v. [read post]
14 May 2019, 11:24 am by Lawrence B. Ebert
USA, Inc., 566 F.3d 989, 994(Fed. [read post]
8 Mar 2025, 9:58 am by Conaway & Strickler, P.C.
An example of a DPA would be one that was entered in to by the DOJ and Teva Pharmaceuticals USA, Inc in August 2023 in response to the that company’s involvement in a price fixing conspiracy involving several pharmaceuticals. [read post]
27 Nov 2018, 9:30 am by Ronald Mann
Teva Pharmaceuticals USA Inc. presents the next one of those cases. [read post]